Tobrex cap. eye. 0.3% fl. 5 ml

Drops eye "Tobrex of ^® " are applied to the treatment of external infections of an eye and adjacent fabrics caused by pathogenic microorganisms, sensitive to Tobramycinum.

Structure

1 ml of solution contains (active ingredient) of Tobramycinum of 3 mg.

Excipients: a benzalkoniya chloride, boric acid, sodium sulfate waterless, sodium chloride, tiloksapol, sulphuric acid and/or sodium hydroxide, water purified.

Contraindication

Hypersensitivity to active agent or to any of medicine components.

Route of administration

As well as at application of other antibiotics, it is necessary to carry out the corresponding monitoring of sensitivity of bacteria to drug.

Use to children, teenagers and adults, including elderly people. At a lung and moderately severe courses of the disease to dig in 1-2 drops in a conjunctival sac(s) of the affected eye (eyes) each 4 hours. At a severe disease to dig in 1-2 drops in a conjunctival sac(s) of the affected eye (eyes) each hour before improvement of a state; frequency of use of medicine should be reduced gradually before complete cessation. Usually treatment lasts 7-10 days.

After instillation recommends careful closing a century or to press in the field of a lacrimonasal opening. It reduces system absorption of the medicaments entered into eyes that reduces the probability of emergence of system side effects.

in case of the accompanying therapy using other local ophthalmologic medicines should observe an interval of 10-15 minutes between their application.

Feature of application

Pregnant

women planning pregnancy can use This drug. "Tobrex of ^® " is not recommended to be applied during pregnancy.

during feeding by a breast if the advantage of use of medicine for mother exceeds risk for the newborn/baby who is nursed.

Children

Exist the data confirming safety and efficiency of use of medicine for children including newborns with conjunctivitis which applied eye drops "Tobrex of ^® " 5 times a day within 7 days.

Drivers

Influence on ability to steer motor transport or other mechanisms during use of medicine "Tobrex of ^® " or it is absolutely insignificant. Temporary turbidity of sight or other disorders of vision can affect ability to steer motor transport or mechanisms. If the illegibility of sight arises during burying, the patient needs to wait until the sight is restored before steering motor transport or to work with other mechanisms.

Overdose

Any toxic influence in case of overdose at topical administration of medicine and also at accidental swallowing maintenance of one bottle, considering characteristics of this medicine, it is not expected.

Possible clinical signs and symptoms of overdose by medicine (a dot keratitis, an erythema, the raised dacryagogue, hypostasis and an itch a century) can be similar to side reactions which were observed at some patients.

Excess of medicine in case of overdose at topical administration needs to be washed up from an eye (eyes) warm water.

Side effects

during clinical trials by the most widespread side reactions were hyperaemia of eyes and sensation of discomfort from eyes which arose approximately in 1.4% and 2% of patients respectively.

to Store

at a temperature not above 25 °C, out of children's reach. To hold a bottle densely closed.

Expiration date - 3 years (after opening of a bottle - 4 weeks).